Bharat Biotech, Aurobindo and Hetero sign multi crore investment deals in Telangana

Ruchika Sharma

Bharat Biotech, Aurobindo and Hetero sign multi crore investment deals in Telangana

Written By : Ruchika Sharma Published On 2025-12-10T16:25:06+05:30 | Updated On 10 Dec 2025 4:26 PM IST

Product basket under Pradhan Mantri Bhartiya Janaushadhi Yojna has 2110 medicines: Minister

Hyderabad: Telangana's investment momentum surged on tuesday as the state government announced over Rs 1 lakh crore investment agreements with industry heavyweights, including Aurobindo Pharma, Hetero, Bharat Biotech, and Reliance Consumer Products Limited on the final day of the ‘Telangana Rising Global Summit 2025’.

This comes on the heels of an impressive Rs 2.43 lakh crore worth of investment MOUs signed on Monday, underscoring the state’s rising appeal as a global business and life sciences hub.

As per PTI, Reliance Consumer Products Limited (RCPL) proposes to set up a multi-product FMCG manufacturing facility for beverages, snacks, confectionery and other consumer products on 100 acres in Telangana with an investment of Rs 1,500 crore. The project is expected to create 1,000 direct jobs.

Vintage Coffee and Beverages Ltd signed an MoU to expand its Telangana operations by establishing an export-oriented premium freeze-dried coffee (FDC) plant with an investment of Rs 1,100 crore.

JCK Infra Projects Limited will set up data centre facilities and ancillary infrastructure services with an investment of Rs 9,000 crore, generating over 2,000 jobs.

RCT Energy India Pvt Ltd proposes to invest Rs 2,500 crore in the state in three phases, creating more than 1,600 jobs.

Hetero Group plans to establish large-scale pharmaceutical formulation facilities in Telangana, enhancing the state’s manufacturing capabilities for domestic and global markets.

The proposed investment of Rs 1,800 crore is expected to generate more than 9,000 direct and indirect jobs over the next two years.

Bharat Biotech plans to set up a state-of-the-art contract research, development and manufacturing organisation (CRDMO) facility in Telangana with an investment of Rs 1,000 crore.

Aurobindo Pharma signed an MoU with the state to expand and develop its capabilities in complex generics, injectables, oral solid formulations, biosimilars and biologics.

The proposed investment of Rs 2,000 crore is expected to create more than 3,000 direct and indirect jobs over the next two to three years.

Investments finalised on the second day stood at Rs 1,04,350 crore, the release added.

reliance consumeraurobindo pharmaheterobharat biotech

Source : with inputs

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751